Mycophenolate mofetil or cyclophosphamide in Indian patients with lupus nephritis : which is better...
Mycophenolate mofetil or cyclophosphamide in Indian patients with lupus nephritis : which is better ? a single-center experience
About this item
Full title
Author / Creator
Publisher
Riyadh, Saudi Arabia: Saudi Center for Organ Transplantation
Journal title
Language
English
Formats
Publication information
Publisher
Riyadh, Saudi Arabia: Saudi Center for Organ Transplantation
Subjects
More information
Scope and Contents
Contents
Mycophenolate mofetil (MMF) is used extensively for the induction therapy of lupus nephritis (LN) and has even outpaced intravenous (i.v.) cyclophosphamide (CyP) as the initial choice of therapy. There are no studies comparing the response of MMF with standard dose i.v. CyP in Indian patients with LN. We conducted a 24-week prospective, randomized,...
Alternative Titles
Full title
Mycophenolate mofetil or cyclophosphamide in Indian patients with lupus nephritis : which is better ? a single-center experience
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_80372a3fb46b4d4fa2aae69e496a1494
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_80372a3fb46b4d4fa2aae69e496a1494
Other Identifiers
ISSN
1319-2442
E-ISSN
2320-3838
DOI
10.4103/1319-2442.215147
